These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23123690)

  • 21. Cost-utility analysis of botulinum toxin type A products for the treatment of cervical dystonia.
    Kazerooni R; Broadhead C
    Am J Health Syst Pharm; 2015 Feb; 72(4):301-7. PubMed ID: 25631837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose conversion ratio, comparative efficacy, and adverse events after switching from onabotulinum toxin A to abobotulinum toxin A for neurological conditions.
    Ozer IS; Kuzu Kumcu M; Tezcan Aydemir S; Akbostanci MC
    Clin Neurol Neurosurg; 2021 Oct; 209():106889. PubMed ID: 34461363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term safety, efficacy, dosing, and development of resistance with botulinum toxin type B in cervical dystonia.
    Berman B; Seeberger L; Kumar R
    Mov Disord; 2005 Feb; 20(2):233-7. PubMed ID: 15455449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term efficacy and safety of botulinum toxin type A (Dysport) in cervical dystonia.
    Truong D; Brodsky M; Lew M; Brashear A; Jankovic J; Molho E; Orlova O; Timerbaeva S;
    Parkinsonism Relat Disord; 2010 Jun; 16(5):316-23. PubMed ID: 20359934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prospective, randomized, double-blind study comparing the efficacy and safety of type a botulinum toxins botox and prosigne in the treatment of cervical dystonia.
    Quagliato EM; Carelli EF; Viana MA
    Clin Neuropharmacol; 2010; 33(1):22-6. PubMed ID: 19959960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term follow-up of cervical dystonia patients treated with botulinum toxin A.
    Haussermann P; Marczoch S; Klinger C; Landgrebe M; Conrad B; Ceballos-Baumann A
    Mov Disord; 2004 Mar; 19(3):303-8. PubMed ID: 15022184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dysport produces intrinsically more swallowing problems than Botox: unexpected results from a conversion factor study in cervical dystonia.
    Dressler D
    J Neurol Neurosurg Psychiatry; 2002 Nov; 73(5):604; author reply 604. PubMed ID: 12397170
    [No Abstract]   [Full Text] [Related]  

  • 28. Outcome predictors, efficacy and safety of Botox and Dysport in the long-term treatment of hemifacial spasm.
    Bentivoglio AR; Fasano A; Ialongo T; Soleti F; Lo Fermo S; Albanese A
    Eur J Neurol; 2009 Mar; 16(3):392-8. PubMed ID: 19364366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minimal effective dose of dysport and botox in a rat model of neurogenic detrusor overactivity.
    Behr-Roussel D; Oger S; Pignol B; Pham E; Le Maux A; Chabrier PE; Caisey S; Compagnie S; Picaut P; Bernabé J; Alexandre L; Giuliano F; Denys P
    Eur Urol; 2012 May; 61(5):1054-61. PubMed ID: 22341129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparing two types of botulinum-A toxin detrusor injections in patients with severe neurogenic detrusor overactivity: a case-control study.
    Grosse J; Kramer G; Jakse G
    BJU Int; 2009 Sep; 104(5):651-6. PubMed ID: 19281462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botulinum toxin A--injection for cervical dystonia.
    Bhaumik S; Behari M
    J Assoc Physicians India; 1999 Mar; 47(3):267-70. PubMed ID: 10999117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A 17-year experience of abobotulinumtoxina in cervical dystonia.
    Vivancos-Matellano F; Ybot-Gorrin I; Diez-Tejedor E
    Int J Neurosci; 2012 Jul; 122(7):354-7. PubMed ID: 22329596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectivity of Dysport in patients with blepharospasm and hemifacial spasm who experienced failure with Botox.
    Badarny S; Susel Z; Honigman S
    Isr Med Assoc J; 2008 Jul; 10(7):520-2. PubMed ID: 18751631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Botulinum toxin type A for the treatment of non-neurogenic overactive bladder: does using onabotulinumtoxinA (Botox(®) ) or abobotulinumtoxinA (Dysport(®) ) make a difference?
    Ravindra P; Jackson BL; Parkinson RJ
    BJU Int; 2013 Jul; 112(1):94-9. PubMed ID: 23490404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of incobotulinumtoxinA (NT 201, XEOMIN®, botulinum neurotoxin type A, without accessory proteins) in patients with cervical dystonia.
    Comella CL; Jankovic J; Truong DD; Hanschmann A; Grafe S;
    J Neurol Sci; 2011 Sep; 308(1-2):103-9. PubMed ID: 21764407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin.
    Van den Bergh P; Francart J; Mourin S; Kollmann P; Laterre EC
    Muscle Nerve; 1995 Jul; 18(7):720-9. PubMed ID: 7783762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. To switch from Botox to Dysport in children with CP, a real world, dose conversion, cost-effectiveness study.
    Tedroff K; Befrits G; Tedroff CJ; Gantelius S
    Eur J Paediatr Neurol; 2018 May; 22(3):412-418. PubMed ID: 29452742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparison of Botox and a Chinese type a botulinum toxin in cervical dystonia].
    Wan X; Tang X
    Zhonghua Yi Xue Za Zhi; 1998 Feb; 78(2):131-4. PubMed ID: 10923426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study).
    Truong DD; Cullis PA; O'Brien CF; Koller M; Villegas TP; Wallace JD
    Mov Disord; 1997 Sep; 12(5):772-5. PubMed ID: 9380065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary results from the cervical dystonia patient registry for observation of onabotulinumtoxina efficacy (CD PROBE).
    Jankovic J; Adler CH; Charles D; Comella C; Stacy M; Schwartz M; Manack Adams A; Brin MF
    J Neurol Sci; 2015 Feb; 349(1-2):84-93. PubMed ID: 25595221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.